ArticleInvestigational new drugs2017

The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.

Augusto Faria Andrade et al.PubMed ↗Publisher ↗

No numbers read from the abstract.